Coronary Stents Market by 2035: Forecast Market Size, Top Trends and Opportunities | Transparency Market Research, Inc.

Cardiovascular diseases (CVDs) remain the foremost cause of mortality globally, with coronary artery disease (CAD) at the heart of this health crisis. In this context, coronary stents-tiny, life-saving devices designed to restore blood flow in clogged coronary arteries-play a pivotal role in managing CAD. As the demand for minimally invasive procedures grows and stent technologies continue to evolve, the coronary stents market is poised for substantial expansion.

In 2024, the global coronary stents market was valued at US$ 7,222.5 million. Forecasts indicate that the market is projected to grow at a CAGR of 5.3% from 2025 to 2035, reaching US$ 12,846.6 million by the end of the forecast period. This robust growth is underpinned by rising prevalence of cardiovascular diseases, increasing patient awareness, enhanced reimbursement policies, and breakthroughs in drug-eluting and bioabsorbable stent technology.

Gain a preview of important insights from our Report in this sample -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23

Understanding Coronary Stents and Their Medical Significance

Coronary stents are small, mesh-like tubes inserted into coronary arteries to treat blockages and ensure adequate blood flow to the heart muscle. Typically used during angioplasty procedures, they provide structural support to narrowed arteries that have been widened using a balloon catheter.

There are three main types of coronary stents:

Bare Metal Stents (BMS): These are the first generation of stents made from stainless steel or cobalt-chromium alloys. While they are effective in physically propping open arteries, they pose a higher risk of restenosis due to tissue regrowth around the stent.

Drug-Eluting Stents (DES): Coated with medications that slowly release into the artery wall, DES significantly reduce the risk of restenosis. These have become the gold standard in interventional cardiology.

Bioabsorbable Vascular Scaffolds (BVS): A newer innovation, BVS are made from materials that gradually dissolve in the body after fulfilling their purpose. This restores natural vascular function and reduces long-term complications.

The choice of stent depends on patient-specific factors such as artery size, location of the blockage, comorbidities, and the potential risk of restenosis.

Market Drivers: Why the Coronary Stents Market Is Booming

Rising Demand for Minimally Invasive Procedures
Modern medicine continues to trend toward procedures that are less invasive yet highly effective. Percutaneous coronary intervention (PCI) has emerged as a preferred treatment option over open-heart surgery for many patients with CAD. PCI procedures, including stenting, offer numerous advantages: shorter hospital stays, reduced pain, lower risk of complications, and quicker recovery times.

As patients become more educated about treatment alternatives and physicians increasingly endorse minimally invasive interventions, the demand for PCI and coronary stents has soared. Notably, drug-eluting stents and bioabsorbable scaffolds have improved the safety and effectiveness of these interventions by addressing key clinical concerns such as restenosis and late thrombosis. The shift toward patient-centered care in healthcare institutions also amplifies the appeal of stenting procedures.

Favorable Reimbursement Policies
The global coronary stents market has greatly benefited from reimbursement policies that enhance patient access and reduce financial barriers. In many countries, government and private insurers have established comprehensive frameworks to support stenting procedures, especially for high-risk populations.

These policies are not only encouraging patients to undergo timely interventions but also incentivizing healthcare providers to adopt advanced stenting technologies. Reimbursement support for DES and BVS, in particular, reflects confidence in their clinical efficacy and safety profiles. Additionally, the shift toward value-based healthcare-where outcomes and cost-effectiveness dictate coverage-promotes adoption of innovative, outcome-driven solutions in coronary interventions.

Product and Material Innovation: Leading Segments in Focus

Drug-Eluting Stents (DES): The Gold Standard
Drug-eluting stents (DES) are the dominant segment in the global coronary stents market, primarily due to their ability to significantly reduce the likelihood of artery re-narrowing. By delivering antiproliferative drugs directly to the artery wall, DES minimize the need for repeat procedures and improve patient outcomes. As clinical data consistently demonstrate superior results for DES across a wide range of patient profiles, these stents have become standard care in both elective and emergency interventions.

Metal Stents: The Backbone of the Market
Despite the rise of bioabsorbable materials, metal stents-especially those made from cobalt-chromium and stainless steel-continue to dominate the market due to their strength, biocompatibility, and flexibility. These materials provide critical radial support and have a long track record of safety. Innovations in metal alloy composition and manufacturing processes are yielding thinner struts and better deliverability, which translates to improved procedural outcomes.

The convergence of drug delivery systems with metal-based scaffolds has been a major technological breakthrough, enabling the stents to offer both mechanical support and pharmacological action.

Review our report to gain deeper insights and understanding -

https://www.transparencymarketresearch.com/coronary-stents-market.html

Regional Market Insights

North America: The Market Leader
North America, led by the United States, holds the largest share of the coronary stents market. This dominance is driven by a combination of high disease prevalence, advanced healthcare infrastructure, and rapid adoption of next-generation medical technologies. Strong reimbursement systems and robust R&D ecosystems further support North America's leadership in the market.

Europe: A Mature Yet Innovative Market
Europe remains a mature market with steady growth. Countries like Germany, France, and the UK have well-established interventional cardiology frameworks and are early adopters of new stent technologies. Regulatory support for innovation and public health initiatives focused on cardiovascular disease prevention continue to shape the European landscape.

Asia Pacific: The Fastest-Growing Region
Asia Pacific is experiencing rapid growth due to increasing awareness of cardiovascular health, expanding access to healthcare, and rising middle-class populations. Countries like China and India are seeing a surge in stent procedures, supported by public and private healthcare investments. Local manufacturers are also gaining prominence, offering cost-effective stent solutions tailored to regional needs.

Other Regions
Latin America and the Middle East & Africa are emerging markets with strong growth potential. As healthcare infrastructure improves and cardiovascular disease burdens increase, these regions are expected to adopt advanced stenting procedures more widely.

Competitive Landscape and Strategic Developments

The global coronary stents market is highly competitive, with leading players focused on product innovation, strategic collaborations, and regulatory approvals. Key companies include:

Abbott Laboratories

Boston Scientific Corporation

Medtronic plc

Elixir Medical Corp.

MicroPort Scientific Corporation

Biosensors International

Terumo Corporation

Recent Developments:
In October 2024, Elixir Medical reported that its DynamX Coronary Bioadaptor System significantly reduced target lesion failure compared to conventional DES in complex patient populations, as per the INFINITY-SWEDEHEART RCT.
In May 2024, Abbott launched the XIENCE Sierra in India, a next-generation everolimus DES with improved deliverability and safety for complex cases, offering CE-marked innovation tailored to interventional cardiologists in developing markets.
These developments underline the market's shift toward next-generation stent systems that address complex clinical needs while expanding global access.

Buy this Premium Research Report and unlock critical data and findings -

https://www.transparencymarketresearch.com/checkout.php?rep_id=23<ype=S

Explore Latest Research Reports by Transparency Market Research:

Peptide Therapeutics Contract API Manufacturing Market

https://www.transparencymarketresearch.com/peptide-therapeutics-contract-api-manufacturing-market.html

Pediatric Electronic Health Records Software Market

https://www.transparencymarketresearch.com/pediatric-electronic-health-records-software-market.html

Viral Vectors for Non-human Primates Market

https://www.transparencymarketresearch.com/viral-vectors-for-non-human-primates-market.html

Nucleic Acid Therapeutics Market

https://www.transparencymarketresearch.com/nucleic-acid-therapeutics-market.html

Oxycodone Hydrochloride Market

https://www.transparencymarketresearch.com/oxycodone-hydrochloride-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.